ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 829

Is The Severity Of Knee Osteoarthritis On MRI Associated With Outcome Of Exercise Therapy?

Jesper Knoop1, Joost Dekker2, Marike van der Leeden3,4, Martin van der Esch4, J.P. Klein5, David J. Hunter6, Leo D. Roorda4, Martijn P.M. Steultjens7 and Willem F. Lems8, 1Amsterdam Rehabilitation Research Center, Reade, centre for rehabilitation and rheumatology, Amsterdam, Netherlands, 2Rehabilitation Medicine, Psychiatry and EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, Netherlands, 3Rehabilitation Medicine/EMGO, VU University Medical Center, Amsterdam, Netherlands, 4Amsterdam Rehabilitation Research Center | Reade, Amsterdam, the Netherlands, Amsterdam, Netherlands, 5Radiology, VU University Medical Center, Amsterdam, Netherlands, 6Rheumatology, Institute of Bone and Joint Research, Kolling Institute, University of Sydney, Sydney, Australia, 7Institute for Applied Health Research and School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, Scotland, 8Rheumatology, VU University Medical Center, Amsterdam, Netherlands

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: exercise, Knee, Magnetic resonance imaging (MRI), osteoarthritis and physical therapy

  • Tweet
  • Email
  • Print
Session Information

Title: ACR/ARHP Combined Rehabilitation Abstract Session

Session Type: Combined Abstract Sessions

Background/Purpose:

To evaluate associations between severity of knee osteoarthritis (OA) on MRI and treatment outcome in knee OA patients treated with exercise therapy.

Methods:

Ninety-five participants with knee OA in a 12-week exercise program had obtained 3.0 Tesla MRI scans of the knee joint, prior to treatment. MRI data were systematically assessed for OA severity of multiple features (cartilage loss, bone marrow lesions, osteophytes, effusion/synovitis, and meniscal abnormalities) according to the BLOKS scoring system. Regression analyses were performed to analyze associations between OA severity on MRI and outcome of exercise therapy, i.e. changes in activity limitations (WOMAC physical function; primary outcome), pain (NRS), and upper leg muscle strength, and treatment response (OMERACT-OARSI criteria).

Results:

Improvements of on average 24%, 34%, and 21% in WOMAC physical function, NRS pain and upper leg muscle strength, respectively, after 12-week exercise therapy were found. Moderate-to-severe patellofemoral (PF) cartilage loss was significantly associated with less improvements in both activity limitations (p=.01) and upper leg muscle strength (p=.04), while moderate-to-severe PF osteophytes with less improvements in upper leg muscle strength (p<.01). Severity of other features on MRI were not found to be associated with treatment outcome.

Conclusion: Effectiveness of exercise therapy was found to be independent of OA severity on MRI, except for cartilage loss and osteophytes, both in the PF compartment. Our study suggests that all grades of OA severity on MRI can benefit from professionally supervised exercise therapy, although effects might be reduced in patients with advanced PF OA.


Disclosure:

J. Knoop,
None;

J. Dekker,
None;

M. van der Leeden,
None;

M. van der Esch,
None;

J. P. Klein,
None;

D. J. Hunter,
None;

L. D. Roorda,
None;

M. P. M. Steultjens,
None;

W. F. Lems,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/is-the-severity-of-knee-osteoarthritis-on-mri-associated-with-outcome-of-exercise-therapy/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology